Nanobiotix SA NBTX:NASDAQ

RT Quote | USD
Last | 05/16/24 EDT
7.26quote price arrow down-0.05 (-0.68%)
Volume
2,557
52 week range
4.55 - 11.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.31
  • 52 Week High11.00
  • 52 Week High Date08/23/23
  • 52 Week Low4.55
  • 52 Week Low Date05/31/23

Key Stats

  • Market Cap342.188M
  • Shares Out47.13M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-0.27

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.31
  • 52 Week High11.00
  • 52 Week High Date08/23/23
  • 52 Week Low4.55
  • 52 Week Low Date05/31/23
  • Market Cap342.188M
  • Shares Out47.13M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-0.27

RATIOS/PROFITABILITY

  • EPS (TTM)-1.20
  • P/E (TTM)-6.07
  • Fwd P/E (NTM)-5.50
  • EBITDA (TTM)-27.429M
  • ROE (TTM)-198.69%
  • Revenue (TTM)32.658M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-132.08%
  • Debt To Equity (MRQ)-2,609.93%

EVENTS

  • Earnings Date05/22/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nanobiotix SA

 

Profile

MORE
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to...
Bart Van Rhijn
Chief Financial Officer, Member of the Management Board
Address
60 rue de Wattignies
Paris
75012
France